Testosterone therapy for low testosterone in men with low-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether testosterone replacement therapy can safely improve low testosterone levels in men with low-risk prostate cancer who are not getting immediate treatment. It aims to help men feel better without worsening their cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older.
- You have low-risk or favorable intermediate-risk prostate cancer and are being watched closely (active surveillance).
- You do not have high-risk or very high-risk prostate cancer.
- You do not have conditions that make testosterone therapy unsafe, such as advanced prostate cancer, male breast cancer, or poorly controlled heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.
This trial tests whether giving hormone therapy (androgen deprivation therapy) before surgery can improve outcomes for men with high-risk prostate cancer. You will receive a special PSMA PET/CT scan to see how the cancer responds.
This trial tests whether an exercise program can help men with early-stage prostate cancer who are being monitored instead of treated. If you are not very active now, you may be able to join a structured exercise plan to see if it improves your health and cancer signs.
This study tests whether tamoxifen, a pill that blocks estrogen, can help your testosterone levels recover faster after you finish hormone therapy for prostate cancer. It may reduce side effects like fatigue and low sex drive.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.
This trial tests a short course of hormone therapy (androgen deprivation therapy) for men with a certain type of prostate cancer that is considered high-risk. The goal is to see if a shorter treatment period can still control the cancer while reducing side effects.
Hear when a new Stage I Prostate Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.